Abstract:Comprehensive profiling of genome and transcriptome has identified myriads of alternations at the level of gene and gene expression, which drive malignant development and progression in context of oncology. As a result, qualitative or quantitative changes of protein expression pattern will inevitably ensue during multi-stage of carcinogenesis. In this sense, the proteome is a functional translation of the genome and is the actual manipulator of cellular behavior. Therefore, proteomic profiling of cellular protein constituents should generate the most relevant marker of the functional state of a cell. On the other hand, lack of correlation between mRNA and protein expression have been documented for a variety of genes. Unlike the genome which is static in certain sense, the proteome of a cell is dynamic and changes over time in terms of protein pattern, protein interactions and modifications triggered by external or internal signals[Kolch et al., 2004; Kolch et al., 2005]. Only dynamic information flow through protein circuitry reflects the course of a disease and allows us to track the pathogenetic mechanisms as well as treatment response[Kolch et al., 2005]. Furthermore, examining DNA sequences and measuring mRNA expression do not specify splicing, post-translational modifications, cleavages, protein subcellular localization and complex formations[Banks et al., 2000; Chambers et al., 2000]. There exists a huge information gulf between RNA transcription and protein expression. Proteome represents a much richer source for the functional description of diseases and the biomarker discovery implicated in cancer. Moreover, most of diagnostic assays currently applied in clinical practice are protein-based immunological methods, which are well adapted to standardization and clinical implementation. Proteomic profiling during disease formation and evolution not only provides an integrated understanding of pathogenesis in context of genome and proteome but also holds greater promise to identify the biomarkers of diagnosis and therapeutic targets for diseases such as cancer.

Title Comparative proteomic analysis of esophageal squamous cellcarcinoma

Comparative Proteomic Analysis of Esophageal Squamous Cell Carcinoma

Proteomic profiling of proteins dysregulted in Chinese esophageal squamous cell carcinoma

Proteomic Study of Esophageal Squamous Cell Carcinoma

Pathway Analysis of Differentially Expressed Genes in Human Esophageal Squamous Cell Carcinoma.

Proteomic identification of malignant transformation-related proteins in esophageal squamous cell carcinoma

iTRAQ-Based Quantitative Proteomic Analyses of High Grade Esophageal Squamous Intraepithelial Neoplasia.

Proteomics Studies in Esophageal Squamous Cell Carcinoma

Comparative Proteomic Analysis Of The Esophageal Squamous Carcinoma Cell Line Ec109 And Its Multi-Drug Resistant Subline Ec109/Cddp

Tubulin beta chain, filamin A alpha isoform 1, and cytochrome b-c1 complex subunit 1 as serological diagnostic biomarkers of esophageal squamous cell carcinoma: a proteomics study

Identification of the Up-Regulation of TP-alpha, Collagen Alpha-1(Vi) Chain, and S100A9 in Esophageal Squamous Cell Carcinoma by a Proteomic Method.

Preliminary Analysis of Differentially Expressed Genes in Esophageal Carcinoma Tissues

Comparative proteomic study for profiling differentially expressed proteins between Chinese left- and right-sided colon cancers.

Tissue Microarray Analysis Reveals a Tight Correlation Between Protein Expression Pattern and Progression of Esophageal Squamous Cell Carcinoma

Identification of Distinct Gene Expression Profiles Between Esophageal Squamous Cell Carcinoma and Adjacent Normal Epithelial Tissues

N-linked glycoproteomic profiling in esophageal squamous cell carcinoma

Analysis of serum proteomic pattern between patients with esophageal cancer and precancerous lesions in high risk area

Discovery and Validation of Combined Biomarkers for the Diagnosis of Esophageal Intraepithelial Neoplasia and Esophageal Squamous Cell Carcinoma

Proteins Profile in Esophageal Multistage Carcinogenesis

Serum proteomics unveil characteristic protein diagnostic biomarkers and signaling pathways in patients with esophageal squamous cell carcinoma

Identification of Alpha-Actinin 4 and 67 Kda Laminin Receptor As Stage-Specific Markers in Esophageal Cancer Via Proteomic Approaches